Fundraising Fox
Find your path to John
Sign up to see every warm intro you have to John
- Paths you didn't know you had: your email and LinkedIn already hold routes to John. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
John Clarke is a Managing Partner at Cardinal Partners, which he co-founded in 1997, and brings over three decades of early-stage venture capital experience. He leads the firm's life sciences investment practice and has led or directed investments in multiple publicly traded pharmaceutical and healthcare companies. Prior to Cardinal, he spent 15 years at DSV Partners, where he managed the firm's healthcare and life sciences portfolio and served as interim CEO of several successful companies.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Deals · 4
Cardinal AnalytxBoard seat
via Cardinal Partners · filed Mar 2018 · $2M raise
aTYR PHARMABoard seat
via Cardinal Partners · filed Apr 2015 · $76.3M raise
AlkermesLed round
VerastemLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Alnylam PharmaceuticalsArris PharmaceuticalsCubist PharmaceuticalsDNXMomenta PharmaceuticalsSirtris Pharmaceuticals
Board seats
Abide TherapeuticsIvenixTechRx CorporationVisicuVividion Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Cardinal Partners
Network1
Investors connected to John in public investor directories — a warm-intro map.
Frequently asked questions
- Who is John Clarke?
- John Clarke is a Managing Partner at Cardinal Partners, which he co-founded in 1997, and brings over three decades of early-stage venture capital experience. He leads the firm's life sciences investment practice and has led or directed investments in multiple publicly traded pharmaceutical and healthcare companies. Prior to Cardinal, he spent 15 years at DSV Partners, where he managed the firm's healthcare and life sciences portfolio and served as interim CEO of several successful companies.
- Where does John Clarke work?
- John Clarke is Managing Partner at Cardinal Partners.
- What does John Clarke invest in?
- John Clarke invests in Biotech, Healthtech, Medical Devices.
- What boards does John Clarke sit on?
- John Clarke holds tracked board seats at Abide Therapeutics, aTyr Pharma, aTYR PHARMA, Cardinal Analytx, Ivenix, TechRx Corporation, Visicu, Vividion Therapeutics.
- What companies has John Clarke invested in?
- Investments tracked here include Alkermes, Alnylam Pharmaceuticals, Arris Pharmaceuticals, Cubist Pharmaceuticals, DNX, Momenta Pharmaceuticals, Sirtris Pharmaceuticals, Verastem.
- Does John Clarke lead rounds?
- Yes — John Clarke has led 8 tracked investments.
About this profile. Compiled from public sources — Cardinal Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights